Healthcare Finance News November 2, 2019
The Centers for Medicare and Medicaid Services has finalized major policy changes including a controversial decision to move forward with site neutral payments and to make cuts to the 340B drug program.
CMS will complete a two-year phase-in of site neutral payments for clinic visits to off-campus hospital outpatient settings, despite a district court ruling earlier this year that went against the cuts. The agency said it is evaluating its options to appeal.
“We acknowledge that the United States District Court for the District of Columbia vacated the volume control policy for CY 2019 and we are working to ensure affected 2019 claims for clinic visits are paid consistent with the court’s order,” CMS said. “We do not believe it...
Today's Sponsors
Today's Sponsor